Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 32,607 shares at $8.66 ($294K) on 2024-12-11, disclosed to the SEC on 2024-12-11.
Open-market sale of $294k OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.37 | 8,256 | $77K | 26.3% |
| 2 | $9.37 | 8,256 | $77K | 26.3% |
| 3 | $8.66 | 7,958 | $69K | 23.4% |
| 4 | $8.66 | 7,958 | $69K | 23.4% |
| 5 | $9.39 | 179 | $2K | 0.6% |
| Total | $9.02 avg | 32,607 |
| $294K |
| 100% |
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |